Showing results (101-110 of 666) with videos related to
Sort By:
Pageof 67
Pediatric Blood & Cancer|September 18, 2010
The controversy of varicella vaccination in children with acute lymphoblastic leukemiaMiguela A Caniza, Stephen P Hunger, Andre Schrauder, et al.Cancer Epidemiology|April 24, 2010
Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemiaWing Leung, Geoffrey Neale, Fred Behm, et al.Cancer Chemotherapy and Pharmacology|May 19, 2004
Late-onset delayed excretion of methotrexateJennifer L Pauley, John Carl Panetta, Jeffrey Schmidt, et al.Cancer|January 27, 2010
Adult acute lymphoblastic leukemia: concepts and strategiesStefan Faderl, Susan O'Brien, Ching-Hon Pui, et al.Pediatric Blood & Cancer|September 1, 2007
Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemiaJessica R Roberson, Mihaela Onciu, Stanley Pounds, et al.Cancer|November 30, 2006
Prognostic factors and outcome of recurrence in childhood acute myeloid leukemiaJeffrey E Rubnitz, Bassem I Razzouk, Shelly Lensing, et al.The Lancet. Oncology|November 2, 2013
Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013Allen E J Yeoh, Daryl Tan, Chi-Kong Li, et al.Blood|August 19, 2006
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya, John C Panetta, Yinmei Zhou, et al.Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.Pageof 67